IP Library Granted Patent US 9,211,360
Granted Patent B2
US 9,211,360 · App. 13/888,640 · Granted Dec 15, 2015

Bone graft

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,211,360
App. No.
13/888,640
Granted
Dec 15, 2015
Kind
B2
Abstract

A method for producing a bone matrix scaffold has the steps of providing at least one sheet material and cross-linking the at least one sheet material using fibers. The sheet material has a surface pattern that enhances osteo-conductivity and potentially supports inductivity. The surface pattern is a 3-dimensional substantially continuous network having voids. The combination of the at least one sheet and fibers form a macrostructure having substantially continuous network and voids.

Claims (42)

1. A method for producing a bone matrix scaffold, comprising the steps of

providing at least one sheet material the sheet material having a surface pattern that enhances osteo-conductivity and potentially supports inductivity, wherein the surface pattern is a 3-dimensional substantially continuous network having voids, the surface pattern mimics an under-modelled marine mammal having a greater trabecular thickness and spacing and a lower connectivity and trabecular number for equalized total volume compared to adult human bone morphology, the trabecular morphology exhibiting;

BIOPSY

BV/TV

BS/BV

TbTh

TbSp

TbN

Ost#

Cross

17.71

14.98

135.16

631.70

1.33

230/mm 2

Long

24.64

 8.67

231.05

710.09

1.06

150/mm 2

cross-linking said at least one sheet material using fibers; and

whereby a macrostructure is formed having a substantially continuous network and voids.

2. The method according to claim 1 , wherein at least two sheets of material are cross-linked, each sheet having the surface pattern, wherein the surface pattern mimics whale bone morphology having the defined trabecular morphology.

3. The method according to claim 2 , wherein a laminate structure consisting of said at least two sheets of material is formed.

4. The method according to claim 1 , wherein a semi-solid network, a gel, is formed.

5. The method according to claim 1 , wherein said fibers comprise at least one polymer and/or a mixture of polymers.

6. The method according to claim 5 , wherein said at least one polymer is a copolymer having carboxylic acid groups and/or amine groups.

7. The method according to claim 5 , wherein said at least one polymer is a conductive polymer selected from polypyrrole, polyaniline, polyacetylene, and polythiophene and mixtures thereof.

8. The method according to claim 1 , wherein said fibers are collagen fibers.

9. The method according to claim 8 , wherein said fibers represent non-aldehyde cross-linked Type I collagen.

10. The method according to claim 8 , wherein said collagen is chemically cross-linked with nordihydroguaiaretic acid.

11. The method according to claim 1 , wherein said voids are formed to define openings and the average diameter of said openings and the average diameter of a cross-section of said network is formed to have a ratio of from 2:1 to 10:1.

12. The method according to claim 11 , wherein said ratio is from 2:1 to 5:1.

13. The method according to claim 1 , wherein less than 10% of said voids of said macrostructure are formed to have a fractal dimension higher than 1.

14. The method according to claim 1 , wherein the exterior surface of said scaffold is made porous.

15. The method according to claim 1 , further comprising the step of incubating said macrostructure with cells for a predetermined period of time.

16. The method according to claim 15 , wherein said cells are selected from the group of living cells and recombinant cells, chondrocytes, and growth factor producing cells.

17. The method according to claim 15 , wherein the size of said macrostructure changes less than 50% when said cells are added to the matrix.

18. The method according to claim 15 further comprising removing said cells from said macrostructure.

Assignments (10)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 2, 2021
From: GANEY, TIMOTHY
To: AMENDIA, INC.
Reel/Frame 057370/0310 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2021
From: GANEY, TIMOTHY
To: BONE PHARM, LLC
Reel/Frame 055780/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2020
From: VIVEX BIOMEDICAL, INC.
To: GANEY, TIMOTHY
Reel/Frame 053772/0339 →
RELEASE OF SECURITY INTEREST Recorded Dec 12, 2019
From: HERITAGE BANK OF COMMERCE
To: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
Reel/Frame 051282/0653 →
RELEASE OF SECURITY INTEREST Recorded Mar 28, 2017
From: SILICON VALLEY BANK
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 042103/0686 →
SECURITY INTEREST Recorded Feb 22, 2017
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 041782/0452 →
RELEASE OF SECURITY INTEREST Recorded Apr 29, 2016
From: SILICON VALLEY BANK, AS ADMINISTRATIVE AGENT
To: AMENDIA, INC.; OMNI ACQUISITION INC.
Reel/Frame 038578/0828 →
SECURITY INTEREST Recorded Jan 5, 2016
From: VIVEX BIOMEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 037413/0089 →
PATENT SECURITY AGREEMENT Recorded Sep 9, 2014
From: AMENDIA, INC.; OMNI ACQUISITION, INC.
To: SILICON VALLEY BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 033696/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2014
From: AMENDIA, INC.
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 033629/0745 →